Merck KGaA
MKGAF
$129.45
-$4.45-3.32%
OTC PK
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -1.72% | 4.25% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -1.72% | 4.25% | |||
| Cost of Revenue | 4.30% | -2.67% | |||
| Gross Profit | -5.67% | 9.34% | |||
| SG&A Expenses | 4.62% | 1.90% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | 61.11% | -208.97% | |||
| Total Operating Expenses | 5.06% | -3.29% | |||
| Operating Income | -24.49% | 41.16% | |||
| Income Before Tax | -64.45% | 39.54% | |||
| Income Tax Expenses | -65.92% | 33.21% | |||
| Earnings from Continuing Operations | -64.07% | 41.23% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -224.46% | 237.35% | |||
| Net Income | -64.79% | 42.51% | |||
| EBIT | -24.49% | 41.16% | |||
| EBITDA | -22.43% | 30.53% | |||
| EPS Basic | -64.71% | 42.16% | |||
| Normalized Basic EPS | -3.16% | 40.81% | |||
| EPS Diluted | -64.71% | 42.16% | |||
| Normalized Diluted EPS | -3.16% | 40.81% | |||
| Average Basic Shares Outstanding | -0.22% | 0.25% | |||
| Average Diluted Shares Outstanding | -0.22% | 0.25% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||